Hms Holdings Corp (HMSY) 17.22 $HMSY HMS Holdings Down

New Post Public Reply Private Reply Replies (0) Message Board

Apr 22, 2015 at 9:55 PM

Hms Holdings Corp (HMSY) 17.22 $HMSY

HMS Holdings Down 21.5% Since SmarTrend Downtrend Call (HMSY)
Comtex SmarTrend(R) - Fri Apr 17, 10:03AM CDT
SmarTrend identified a Downtrend for HMS Holdings (NASDAQ:HMSY) on February 2nd, 2015 at $19.56. In approximately 2 months, HMS Holdings has returned 21.49% as of today's recent price of $15.36.
HMSY: 17.22 (+0.52)

HMS Holdings Has Returned 20.4% Since SmarTrend Recommendation (HMSY)
Comtex SmarTrend(R) - Fri Apr 10, 9:31AM CDT
SmarTrend identified a Downtrend for HMS Holdings (NASDAQ:HMSY) on February 2nd, 2015 at $19.56. In approximately 2 months, HMS Holdings has returned 20.40% as of today's recent price of $15.57.
HMSY: 17.22 (+0.52)

20.5% Return Seen to Date on SmarTrend HMS Holdings Call (HMSY)
Comtex SmarTrend(R) - Thu Apr 02, 5:34PM CDT
SmarTrend identified a Downtrend for HMS Holdings (NASDAQ:HMSY) on February 2nd, 2015 at $19.56. In approximately 2 months, HMS Holdings has returned 20.50% as of today's recent price of $15.55.
HMSY: 17.22 (+0.52)

17.4% Return Seen to Date on SmarTrend HMS Holdings Call (HMSY)
Comtex SmarTrend(R) - Thu Mar 26, 9:29AM CDT
SmarTrend identified a Downtrend for HMS Holdings (NASDAQ:HMSY) on February 2nd, 2015 at $19.56. In approximately 2 months, HMS Holdings has returned 17.38% as of today's recent price of $16.16.
HMSY: 17.22 (+0.52)

What Falling Estimates & Price Mean for HMS Holdings (HMSY) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 26, 7:40AM CDT
HMS Holdings has witnessed a significant price decline in the past four weeks, and it has seen negative earnings estimate revisions for the current quarter and the current year.
MRGE: 5.57 (+0.06), HMSY: 17.22 (+0.52)

Moving Average Crossover Alert: HMS Holdings (HMSY) - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Mar 19, 8:15AM CDT
Moving Average Crossover Alert: HMS Holdings (HMSY)
HMSY: 17.22 (+0.52)

Downtrend Call Working As HMS Holdings Stock Falls 14.1% (HMSY)
Comtex SmarTrend(R) - Wed Mar 11, 11:31AM CDT
SmarTrend identified a Downtrend for HMS Holdings (NASDAQ:HMSY) on February 2nd, 2015 at $19.56. In approximately 1 month, HMS Holdings has returned 14.11% as of today's recent price of $16.80.
HMSY: 17.22 (+0.52)

Upgrade Alert for HMS Holdings (HMSY)
Comtex SmarTrend(R) - Tue Mar 10, 7:06AM CDT
HMS Holdings (NASDAQ:HMSY) was upgraded from Neutral to Buy at Dougherty today. The stock closed yesterday at $16.94 on volume of 1.3 million shares, above average daily volume of 890,000. In the past 52 weeks, shares of HMS Holdings have traded between a low of $15.10 and a high of $37.19 and closed yesterday at $16.94, which is 12% above that low price. In the last five trading sessions, the 50-day moving average (MA) has fallen 1.3% while the 200-day MA has remained constant.
HMSY: 17.22 (+0.52)

HMS (HMSY) CEO Bill Lucia on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Fri Feb 27, 11:10AM CST

HMSY: 17.22 (+0.52)

HMS Holdings (HMSY) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Fri Feb 27, 7:25AM CST

HMSY: 17.22 (+0.52)

More on HMS Holdings' Q4
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 6:18AM CST

HMSY: 17.22 (+0.52)

HMS Holdings reports 4Q loss
Automated Insights - Fri Feb 27, 5:18AM CST
IRVING, Texas (AP) _ HMS Holdings Corp. (HMSY) on Friday reported a fourth-quarter loss of $2.4 million, after reporting a profit in the same period a year earlier.
HMSY: 17.22 (+0.52)

HMS Holdings misses by $0.13, misses on revenue
Seeking Alpha - at Seeking Alpha - Fri Feb 27, 5:04AM CST

HMSY: 17.22 (+0.52)

Notable earnings before Friday’s open
Seeking Alpha - at Seeking Alpha - Thu Feb 26, 4:30PM CST

GLOG: 23.41 (+0.40), DFRG: 19.95 (-0.21), AAON: 24.52 (+0.16), DCIX: 2.52 (+0.03), TTI: 7.15 (-0.02), SJI: 52.88 (-0.17), CNCE: 14.83 (+0.26), XLS: 24.73 (+0.04), PNM: 27.89 (+0.44), NWN: 47.89 (-0.36), GDP: 3.58 (-0.10), HTH: 19.71 (+0.27), CAS: 3.82 (-0.13), HZNP: 30.96 (+0.10), PTCT: 70.98 (unch), WMC: 14.76 (+0.04), GVA: 35.66 (-0.16), CST: 43.54 (-0.12), LBY: 40.35 (-0.28), HPT: 31.36 (-0.46), KERX: 11.52 (-0.15), POM: 26.20 (+0.12), ISIS: 66.26 (-0.03), CVT: 27.80 (+0.12), HMSY: 17.22 (+0.52), NYLD: 51.04 (-0.55), RDC: 19.42 (-0.13), NRG: 25.07 (-0.40), NRF: 18.87 (+0.19)

Joel Portice Named New Intermedix Chief Executive Officer
PRWeb - Wed Feb 11, 11:02AM CST
Intermedix Corporation, a leader in technology-enabled health and safety solutions, announced Wednesday that Joel Portice will succeed Doug Shamon as the company's new chief executive officer.
HMSY: 17.22 (+0.52)

'Mad Money' Lightning Round: Stop Fretting and Buy, Buy, Buy Sirius XM
at The Street - Wed Feb 11, 5:00AM CST
Cramer says stick with Taser and take UnitedHealth or Humana over HMS Holdings.
BAX: 70.38 (+0.33), ACHN: 10.01 (-0.13), UNH: 117.81 (-1.47), SYY: 37.63 (+0.03), TASR: 29.50 (unch), HMSY: 17.22 (+0.52), SIRI: 3.94 (unch), REGN: 472.63 (+9.41), HUM: 180.01 (-0.12), CELG: 115.54 (+0.72)

Baxter Needs To Split Up - Cramer's Lightning Round (2/10/15)
SA Editor Mohit Manghnani - at Seeking Alpha - Wed Feb 11, 4:28AM CST
Stocks discussed on the Lightning Round segment of Jim Cramer's Mad Money Program, Tuesday, February 10. Bullish Calls: Achillion Pharmaceuticals (NASDAQ: ACHN ): " We have said it's a decent spec off of another Hep C," said Cramer....
CI: 130.25 (-0.45), BAX: 70.38 (+0.33), ACHN: 10.01 (-0.13), UNH: 117.81 (-1.47), SYY: 37.63 (+0.03), HMSY: 17.22 (+0.52), TASR: 29.50 (unch), SIRI: 3.94 (unch), REGN: 472.63 (+9.41), HUM: 180.01 (-0.12), CELG: 115.54 (+0.72)

Jim Cramer's 'Mad Money' Recap: No Foreign News Is Great U.S. News
at The Street - Tue Feb 10, 7:35PM CST
With no distractions, the U.S stock market rallied on a slew of terrific company news.
BIIB: 423.57 (+1.46), UNH: 117.81 (-1.47), SYY: 37.63 (+0.03), HOT: 83.51 (-0.22), HUM: 180.01 (-0.12), SBUX: 48.33 (-0.04), SAVE: 77.25 (+0.19), MAT: 28.36 (+1.14), CMG: 641.23 (-51.29), TASR: 29.50 (unch), REGN: 472.63 (+9.41), SIRI: 3.94 (unch), KO: 41.31 (+0.53), HAS: 71.73 (-1.82), DIS: 107.94 (+0.26), ALKS: 62.60 (-0.24), MAS: 26.85 (+0.50), ARO: 3.40 (+0.05), CELG: 115.54 (+0.72), URBN: 42.17 (+0.03), BAX: 70.38 (+0.33), ACHN: 10.01 (-0.13), GM: 37.16 (unch), YELP: 50.45 (+1.14), HMSY: 17.22 (+0.52)

HMS Holdings Corp. To Report 4Q and Full-Year 2014 Financial and Operating Results
Business Wire - Mon Feb 09, 3:15PM CST
HMS Holdings Corp. (NASDAQ:HMSY) today announced it will report fourth quarter and full-year 2014 financial and operating results at 7:30 am CT/8:30 am ET on Friday, February 27, 2015. Supplemental financial information, including the press release and presentation, will be released at approximately 5:00 am CT/ 6:00 am ET and will also be available on the Company's investor relations site at http://investor.hms.com/events.cfm.
HMSY: 17.22 (+0.52)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Windward Bio Surges 68% in Nasdaq Debut

By Ryan Hughes Updated Nov 13, 2026 Category News Views 243

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

Retirement Dreams Dashed: 61% Withdraw Early

By Olivia Taylor Updated Nov 14, 2026 Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

SmallRig Boosts Art-Driven Innovation in AI Era

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

HONGQI's EHS4 Launch in Europe: Bridging East and West

Revving Up a New Chapter: HONGQI in Venice There's a new player in the European automotive scene, and it's rolling in with more style than a Venetian gondola. HONGQI, a name that's been turning gears in China since '58, is packing its suitcases full of Eastern elegance and landing straight in Venice with the all-electric EHS4. On November 16, the brand is set to unveil...

Greenberg Traurig's Brad Kaufman: A Mentor of Resolute Impact

A Milestone for Mentorship at Greenberg Traurig In the often cutthroat jungle of law, finding someone who actually gives a damn about you is as rare as finding a unicorn. Yet, there it is—Brad Kaufman, at the helm of Greenberg Traurig's professional development, proving that mentorship can be more than just a checkbox on a quarterly review. Award for Exceptional...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Lilly's Obesity Breakthroughs: A Step Beyond the Scale

Pushing the Boundaries of Obesity Treatment Alright, let's cut through the noise and get to what really matters here. Eli Lilly is taking on obesity treatment like it's Clash of the Titans at this year's ObesityWeek 2026 in Washington, D.C. Forget just dropping pounds—Lilly wants to reshape how we think about obesity entirely. They're not just leaning into the scale,...

Novo's Research Unlocks New Insights into Food Noise

Unpacking the Science Behind Food Noise When folks think about losing weight, most picture shedding pounds and fitting into those elusive smaller jeans. But get this—there’s a curveball called ‘food noise’ that’s making waves in obesity treatment. Novo Nordisk’s semaglutide injections are shaking things up, cutting down on those persistent thoughts about food....